BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17907056)

  • 1. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.
    Kasibhatla B; Wos J; Peters KG
    Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S; Fantus IG
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
    Harley EA; Levens N
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
    Liu G; Trevillyan JM
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes.
    Tobin JF; Tam S
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):500-12. PubMed ID: 12197308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatase 1B inhibitors for diabetes.
    Johnson TO; Ermolieff J; Jirousek MR
    Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551.
    Fukuda S; Ohta T; Sakata S; Morinaga H; Ito M; Nakagawa Y; Tanaka M; Matsushita M
    Diabetes Obes Metab; 2010 Apr; 12(4):299-306. PubMed ID: 20380650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
    Wang C; Wang L; Yang Z
    Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
    Popov D
    Biochem Biophys Res Commun; 2011 Jul; 410(3):377-81. PubMed ID: 21683066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress of several protein tyrosine phosphatases in diabetes].
    Chen M; Sun JP; Liu J; Yu X
    Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling.
    Erbe DV; Klaman LD; Wilson DP; Wan ZK; Kirincich SJ; Will S; Xu X; Kung L; Wang S; Tam S; Lee J; Tobin JF
    Diabetes Obes Metab; 2009 Jun; 11(6):579-88. PubMed ID: 19383031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dammaranes from Gynostemma pentaphyllum and synthesis of their derivatives as inhibitors of protein tyrosine phosphatase 1B.
    Xu JQ; Shen Q; Li J; Hu LH
    Bioorg Med Chem; 2010 Jun; 18(11):3934-9. PubMed ID: 20472439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioguided isolation of (9Z)-octadec-9-enoic acid from Phellodendron amurense Rupr. and identification of fatty acids as PTP1B inhibitors.
    Steinmann D; Baumgartner RR; Heiss EH; Bartenstein S; Atanasov AG; Dirsch VM; Ganzera M; Stuppner H
    Planta Med; 2012 Feb; 78(3):219-24. PubMed ID: 22124950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review.
    Verma M; Gupta SJ; Chaudhary A; Garg VK
    Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of protein tyrosine phosphatase 1B inhibitors: model validation and docking studies.
    Saxena AK; Pandey G; Gupta S; Singh AB; Srivastava AK
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2320-3. PubMed ID: 19282172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
    Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
    Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
    Cho H
    Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of triazole-linked beta-C-glycosyl dimers as inhibitors of PTP1B.
    Lin L; Shen Q; Chen GR; Xie J
    Bioorg Med Chem; 2008 Nov; 16(22):9757-63. PubMed ID: 18922697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice.
    Maeda A; Kai K; Ishii M; Ishii T; Akagawa M
    Mol Nutr Food Res; 2014 Jun; 58(6):1177-89. PubMed ID: 24668740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.